section name header

Information

Examination of fluid from the chancre, thin or thick blood smears, buffy coats, lymph node aspirates, bone marrow biopsy specimens, or CSF can reveal the parasite.

Treatment: Sleeping Sickness

Stage 1 disease

  • T. b. rhodesiense: suramin (a test dose of 100-200 mg followed by 20 mg/kg IV on days 1, 5, 12, 18, and 26)
    • - Hypersensitivity reactions and renal damage are the most important adverse effects.
    • - A urinalysis should be done before each dose. Treatment should be discontinued if hematuria or increasing proteinuria is found or if casts are present in the sediment.
  • T. b. gambiense:pentamidine (4 mg/kg daily IM or IV for 10 days)
    • - Serious adverse reactions include nephrotoxicity, abnormal liver function, neutropenia, hypoglycemia, and sterile abscesses.
    • - Suramin is an alternative agent.

Stage 2 disease

  • T. b. rhodesiense: melarsoprol (2.2 mg/kg IV daily for 10 days). To reduce reactive encephalopathy, administer prednisolone (1 mg/kg) with each dose of melarsoprol.
  • T. b. gambiense:Eflornithine (100 mg/kg IV qid for 2 weeks) is the first-line agent. Either melarsoprol (2.2 mg/kg qd IV for 10 days) or nifurtimox (5 mg/kg PO tid for 7 days) plus eflornithine (100 mg/kg IV bid for 7 days) is an alternative.

Outline

Section 7. Infectious Diseases